Rhinocerebral mucormycosis is recognized as a potentially aggressive a
nd commonly fatal fungal infection. The classic presentation is involv
ement of nasal mucosa with invasion of the paranasal sinuses and orbit
. Mucormycosis is most commonly seen in association with diabetic keto
acidosis, but disease demographics have changed with the onset of AIDS
and the advent of powerful immunosuppressive drugs. Treatment include
s aggressive debridement, systemic antifungal therapy, and control of
underlying comorbid factors. Although surgical intervention remains es
sential, advances in medical therapy have permitted a more limited sur
gical approach to minimize functional loss without compromising surviv
al. We present the UCLA experience with rhinocerebral mucormycosis fro
m 1955 to 1995, with emphasis on the evolution of disease presentation
and alternative treatment options.